Boundless Bio, Inc. (BOLD) KPIs and segments

BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30

$2.46+0.00 (0.00%)

Close on Nov 12, 2026Market cap $55.96MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Boundless Bio's business

Coming soon

This tab will track the numbers specific to Boundless Bio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?